Time course of erythrocyte antioxidant activity in patients treated by thrombolysis for acute myocardial infarction

被引:11
作者
Simic, D
Mimic-Oka, J
Pljesa, M
Milanovic, D
Radojevic, S
Ivanovic, B
Kalimanovska-Ostric, D
Matic, D
Simic, T
机构
[1] Univ Belgrade, Sch Med, Inst Biochem, YU-11000 Belgrade, Serbia Monteneg, Serbia
[2] Univ Belgrade, Sch Med, Inst Cardiovasc Dis, Clin Ctr Serbia, YU-11000 Belgrade, Serbia Monteneg, Serbia
来源
JAPANESE HEART JOURNAL | 2003年 / 44卷 / 06期
关键词
thrombolysis; reperfusion; oxidative stress; antioxidant enzymes;
D O I
10.1536/jhj.44.823
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The deleterious effects of free radicals in acute myocardial ischaemia/reperfusion are rather well known. However, the possibility that thrombolysis positively affects the recovery of blood antioxidant capacity in the later postinfarction period, and thus contributes to the better overall outcome of these patients, has not yet been investigated. We followed the time course of erythrocyte antioxidant activity in 45 patients with first acute myocardial infarction (AM1), who were treated with streptokinase. Success of thrombolysis was evaluated by noninvasive clinical signs of reperfusion using continuous vector cardiography. The patients were divided into two groups according to Successful or unsuccessful reperfusion. The control group consisted of 24 healthy subjects. Glutathione peroxidase (GPX) and superoxide dismutase (SOD) were determined immediately after admittance to the hospital (0 hours) and after subsequent thrombolytic therapy (1.5, 6, 12, and 24 hours after initiation of infusion of streptokinase), and 2, 4, and 8 days after AM1. Patients with AM1 had decreased antioxidant enzyme activity at the time of admittance to the hospital. showing that the oxidative/antioxidative balance is disturbed early during the ischemic phase of AM1. In AM1 patients without successful reperfusion, erythrocyte antioxidant enzyme activity remains low during the postinfarction period of 7 days. It call be concluded that prolonged ischemia reduces antioxidant enzyme activity. AM1 patients with successful reperfusion have a significant rise in the activity of antioxidant enzymes within the first hours after thrombolysis, followed by a decrease until the third postinfarction day. During the subsquent postinfarction period, erythrocyte antioxidant activity gradually recovered and reached control levels. These beneficial effects of reperfusion oil erythrocyte antioxidant status might contribute to the better overall prognosis of these patients.
引用
收藏
页码:823 / 832
页数:10
相关论文
共 50 条
[21]   Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardiopulmonary resuscitation [J].
Ruiz-Bailén, M ;
de Hoyos, EA ;
Serrano-Córcoles, MC ;
Díaz-Castellanos, MA ;
Ramos-Cuadra, JA ;
Reina-Toral, A .
INTENSIVE CARE MEDICINE, 2001, 27 (06) :1050-1057
[22]   Efficacy of Rescue Thrombolysis in Patients with Acute Myocardial Infarction: Preliminary Findings [J].
Filippo Maria Sarullo ;
Luigi Americo ;
Pietro Di Pasquale ;
Antonio Castello ;
Francesco Mauri .
Cardiovascular Drugs and Therapy, 2000, 14 :83-89
[23]   Minimising delays to thrombolysis in patients developing acute myocardial infarction in hospital [J].
Mumford, AD ;
Banning, AP .
POSTGRADUATE MEDICAL JOURNAL, 1997, 73 (862) :491-495
[24]   Thrombolysis and percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction [J].
Zeymer, U ;
Neuhaus, KL .
ZEITSCHRIFT FUR KARDIOLOGIE, 2000, 89 :30-40
[25]   Diversity in Response to Thrombolysis with Streptokinase in Patients Presenting With Acute Myocardial Infarction [J].
Waheed, Imran ;
Naqvi, Syed Moazzam Ali ;
Shakoor, Tariq ;
Ghazi, Hassan Ul Banna ;
Bin Baqar, Jaffer ;
Khan, Bilal Zakaria .
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2015, 9 (02) :465-468
[26]   Efficacy of rescue thrombolysis in patients with acute myocardial infarction: Preliminary findings [J].
Sarullo, FM ;
Americo, L ;
Di Pasquale, P ;
Castello, A ;
Mauri, F .
CARDIOVASCULAR DRUGS AND THERAPY, 2000, 14 (01) :83-89
[27]   PRECLINICAL THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION [J].
EGGELING, T ;
KOCHS, M .
HERZ KREISLAUF, 1992, 24 (10) :315-319
[28]   Thrombolysis and adjunctive therapy in acute myocardial infarction [J].
Menon, V ;
Harrington, RA ;
Hochman, JS ;
Cannon, CP ;
Goodman, SD ;
Wilcox, RG ;
Schünemann, HJ ;
Ohman, EM .
CHEST, 2004, 126 (03) :549S-575S
[29]   Ridogrel as an adjunct to thrombolysis in acute myocardial infarction [J].
vanderWieken, LR ;
Simoons, ML ;
Laarman, GJ ;
vandenBrand, M ;
Nijssen, KM ;
Dellborg, M ;
Hermens, W ;
Vrolik, W .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 52 (02) :125-134
[30]   The future of thrombolysis in the treatment of acute myocardial infarction [J].
Bode, C ;
Runge, MS ;
Smalling, RW .
EUROPEAN HEART JOURNAL, 1996, 17 :55-60